Stay updated with breaking news from Nasdaq Acrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Free Report) was upgraded by equities researchers at HC Wainwright from a “neutral” rating to a “buy” rating in a research report issued on Friday, FlyOnTheWall reports. Separately, StockNews.com initiated coverage on shares of AcelRx Pharmaceuticals in a research note on Thursday. They set a “sell” rating for the company. […]
StockNews.com began coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research report released on Thursday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. AcelRx Pharmaceuticals Trading Up 4.3 % NASDAQ ACRX opened at $0.84 on Thursday. The firm has a market capitalization of $9.17 million, a […]
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX – Get Free Report) was the target of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 1,030,000 shares, a growth of 19.7% from the July 15th total of 860,800 shares. Approximately 6.6% of the shares of the company are […]
AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Free Report) will announce its 6/30/2023 earnings results after the market closes on Thursday, August 10th. Analysts expect the company to announce earnings of ($0.53) per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. AcelRx Pharmaceuticals Price Performance Shares […]
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. AcelRx Pharmaceuticals Stock Down 3.6 % Shares of NASDAQ:ACRX opened at $1.07 on Friday. AcelRx Pharmaceuticals has a 52-week low of $0.55 and […]